Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu kazuistiky, časopisecké články, přehledy
PubMed
30109475
DOI
10.1007/s00428-018-2426-x
PII: 10.1007/s00428-018-2426-x
Knihovny.cz E-zdroje
- Klíčová slova
- Biphenotypic sinonasal sarcoma, PAX3-MAML3, PAX3-NCOA1, Prognosis, Recurrence, Sinonasal sarcoma,
- MeSH
- DNA vazebné proteiny genetika MeSH
- dospělí MeSH
- fenotyp MeSH
- forkhead box protein O1 genetika MeSH
- fúze genů MeSH
- fúzní onkogenní proteiny genetika MeSH
- genová přestavba MeSH
- imunohistochemie MeSH
- jaderné proteiny genetika MeSH
- koaktivátor 1 jaderných receptorů genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádorové biomarkery genetika MeSH
- nádory vedlejších dutin nosních diagnóza genetika patologie MeSH
- prognóza MeSH
- sarkom diagnóza genetika patologie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- trans-aktivátory MeSH
- transkripční faktor PAX3 genetika MeSH
- transkripční faktory paired box genetika MeSH
- transkripční faktory genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- přehledy MeSH
- Názvy látek
- DNA vazebné proteiny MeSH
- forkhead box protein O1 MeSH
- FOXO1 protein, human MeSH Prohlížeč
- fúzní onkogenní proteiny MeSH
- jaderné proteiny MeSH
- koaktivátor 1 jaderných receptorů MeSH
- MAML3 protein, human MeSH Prohlížeč
- nádorové biomarkery MeSH
- NCOA1 protein, human MeSH Prohlížeč
- PAX3 protein, human MeSH Prohlížeč
- PAX3-FOXO1A fusion protein, human MeSH Prohlížeč
- trans-aktivátory MeSH
- transkripční faktor PAX3 MeSH
- transkripční faktory paired box MeSH
- transkripční faktory MeSH
Biphenotypic sinonasal sarcoma (BSNS) is a recently recognized type of sarcoma arising exclusively in the sinonasal tract displaying unique clinical course, histopathology, and genetics. Due to its rarity, only case series and case reports are available. In order to provide an overview of the current understanding of this disease, we present a comprehensive review of the literature and present three previously unreported cases of BSNS. A total of 55 genetically characterized and 41 cases without molecular data were identified in the literature. Two-thirds of patients were female and the peak incidence was in the fifth decade. Fatal outcome was rare (two cases with intracranial extension) and local recurrence occurred in 31.6%, all occurring within 5 years after initial treatment. Histologically, BSNS is highly cellular in the majority of cases and composed of fascicles of spindle cells, with entrapped hyperplastic surface epithelium being a frequent finding. The immunohistochemical profile is characteristic due to the biphasic nature of this lesion, with shared features of both myogenic and neural origin. Rhabdomyoblastic differentiation is apparent in a subset of cases. The most common genetic event is the PAX3-MAML3 fusion (58.6%) but isolated PAX3 rearrangement (19.2%), absence of rearrangements (9.1%), PAX3-FOXO1 (8.1%), PAX3-NCOA1 (4%), and isolated MAML3 rearrangement (2%) have also been reported. In conclusion, the recognition of BSNS is crucial due to its relatively indolent clinical course. A selected immunohistochemical panel and/or molecular confirmation can be used to aid in appropriate diagnosis and consequently in prognostication and to avoid overtreatment with chemotherapy regimens used in its mimics.
Coordinator of the International Head and Neck Scientific Group Padua Italy
Department of Pathology Faculty of Medicine in Plzen Charles University Plzen Czech Republic
Department of Pathology Rigshospitalet Copenhagen Denmark
Department of Pathology The University of Texas MD Anderson Cancer Center Houston TX USA
Department of Pathology University Medical Center Utrecht Utrecht Netherlands
Department of Pathology University of Texas Southwestern Medical Center Dallas TX USA
Zobrazit více v PubMed
Curr Opin Oncol. 2003 May;15(3):239-52 PubMed
Am J Surg. 1973 Oct;126(4):547-56 PubMed
Histopathology. 2016 Dec;69(6):930-936 PubMed
Annu Rev Cell Dev Biol. 2007;23:645-73 PubMed
Head Neck Pathol. 2016 Mar;10(1):23-31 PubMed
Am J Surg Pathol. 2017 Dec;41(12):1642-1656 PubMed
APMIS. 2016 Jun;124(6):475-86 PubMed
Mod Pathol. 2014 Jan;27(1):55-61 PubMed
Cancer. 1992 Sep 1;70(5):1089-101 PubMed
Head Neck. 2002 Jan;24(1):52-5 PubMed
J Cell Mol Med. 2008 Dec;12(6A):2281-94 PubMed
APMIS. 2015 Aug;123(8):706-15 PubMed
Zhonghua Bing Li Xue Za Zhi. 2017 Dec 8;46(12):841-846 PubMed
Ann Diagn Pathol. 2018 Apr;33:6-10 PubMed
Head Neck. 1999 Oct;21(7):663-70 PubMed
Genes Chromosomes Cancer. 2010 Mar;49(3):224-36 PubMed
Arch Pathol Lab Med. 2017 May;141(5):718-721 PubMed
Hum Pathol. 2016 Sep;55:44-50 PubMed
Head Neck. 2009 May;31(5):679-88 PubMed
Ann Oncol. 2014 Sep;25 Suppl 3:iii102-12 PubMed
Cancer Res. 1994 Jun 1;54(11):2869-72 PubMed
Gene. 2000 May 16;249(1-2):1-16 PubMed
Am J Surg Pathol. 2016 Jan;40(1):51-9 PubMed
Am J Pathol. 2015 Feb;185(2):563-71 PubMed
Pathologe. 2018 Feb;39(1):18-26 PubMed
Cancer. 1994 Jul 15;74(2):697-702 PubMed
Am J Surg Pathol. 2015 Jun;39(6):826-35 PubMed
Am J Surg Pathol. 2018 Jul;42(7):985-988 PubMed
Am J Surg Pathol. 2018 Oct;42(10):1275-1285 PubMed
BMC Mol Biol. 2004 Aug 25;5:13 PubMed
Mod Pathol. 2015 May;28(5):715-20 PubMed
J Neurosci. 2011 Nov 16;31(46):16651-64 PubMed
J Clin Oncol. 2010 May 1;28(13):2151-8 PubMed
Nat Genet. 2014 Jul;46(7):666-8 PubMed
Genes Chromosomes Cancer. 2016 Jan;55(1):25-9 PubMed
Cancer Res. 2004 Aug 15;64(16):5539-45 PubMed
Genes Chromosomes Cancer. 2018 Apr;57(4):203-210 PubMed
Am J Surg Pathol. 2003 Jun;27(6):737-49 PubMed
Am J Surg Pathol. 2012 Apr;36(4):517-25 PubMed
Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 May;119(5):e265-9 PubMed
Laryngoscope. 2015 Mar;125(3):615-23 PubMed